Replimune Group, Inc. - COMMON STOCK (REPL)

Historical Holders from Q3 2018 to Q3 2025

Symbol
REPL on Nasdaq
CUSIP
76029N106
Type / Class
Equity / COMMON STOCK
Shares outstanding
78.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
82.9M
Holdings value
$348M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
159
Number of buys
95
Number of sells
-96
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Replimune Group, Inc. - COMMON STOCK (REPL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAKER BROS. ADVISORS LP 14.3% $80.7M 11M Baker Bros. Advisors LP Mar 7, 2025
PRICE T ROWE ASSOCIATES INC /MD/ 10.6% $34.8M 8.31M T. Rowe Price Associates, Inc. Sep 30, 2025
RTW INVESTMENTS, LP 8.2% $26.8M 6.4M RTW Investments, LP Sep 30, 2025
Forbion Capital Fund III Cooperatief U.A. 6.1% $30.8M 4.22M Forbion Capital Fund III Cooperatief U.A. Dec 31, 2024
Point72 Asset Management, L.P. 4.7% -16.7% $15.2M -$3.49M 3.63M -18.7% Point72 Asset Management, L.P. Sep 30, 2025
VANGUARD GROUP INC 4.77% $26.3M 3.6M The Vanguard Group Dec 31, 2024
Redmile Group, LLC 0.7% -95% $2.25M -$18.3M 536K -89.1% Redmile Group, LLC Sep 30, 2025

Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 82.9M $348M -$50M $4.19 159
2025 Q2 81M $752M -$9.72M $9.29 173
2025 Q1 82M $799M +$36.9M $9.75 165
2024 Q4 77.9M $943M +$84.9M $12.11 155
2024 Q3 69.6M $763M -$11M $10.96 142
2024 Q2 70.9M $638M +$41.7M $9.00 148
2024 Q1 66.5M $543M +$19.7M $8.17 146
2023 Q4 31.2K $265K -$80.2K $8.51 2
2023 Q3 56.8M $971M +$32.5M $17.11 124
2023 Q2 54.6M $1.27B +$27M $23.22 137
2023 Q1 53.7M $947M +$89.8M $17.66 135
2022 Q4 48.2M $1.31B +$189M $27.20 131
2022 Q3 36.7M $633M -$14.1M $17.27 96
2022 Q2 37.2M $650M +$10.9M $17.48 94
2022 Q1 36.4M $618M -$10.8M $16.98 99
2021 Q4 38.8M $1.05B +$6.31M $27.10 94
2021 Q3 34.9M $1.04B +$4.27M $29.64 95
2021 Q2 34.5M $1.32B -$12.3M $38.42 105
2021 Q1 34.3M $1.05B +$606K $30.51 102
2020 Q4 33.7M $1.29B +$360M $38.15 108
2020 Q3 26.6M $611M +$25.7M $23.02 76
2020 Q2 25.4M $631M +$87.5M $24.85 74
2020 Q1 22.2M $221M -$424K $9.97 55
2019 Q4 22M $316M +$48.1M $14.35 60
2019 Q3 18.6M $258M -$14.7M $13.90 50
2019 Q2 19.5M $286M +$11.5M $14.66 50
2019 Q1 19.1M $291M +$17.7M $15.22 50
2018 Q4 18.1M $181M +$1.49M $10.00 49
2018 Q3 17.9M $289M +$243M $16.10 52